Related Experiment Video
Updated: Jan 20, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Determinants and Prevention of Coronary Disease in Patients With Chronic Kidney Disease
Rebecca Rodin1, Christopher T Chan1
1Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
Insights
Chronic kidney disease (CKD) accelerates cardiovascular disease through inflammation and toxins. This review examines CKD
Area of Science:
- Nephrology and Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) significantly increases cardiovascular morbidity and mortality.
- Traditional risk factors incompletely explain cardiovascular disease severity in CKD patients.
- Uremic toxins, inflammation, and bone/mineral disorders are key contributors to vascular aging in CKD.
Purpose of the Study:
- To explore mechanisms of premature aging and cardiovascular disease in CKD.
- To identify determinants of cardiac disease in CKD patients.
- To outline prevention and treatment strategies for cardiovascular complications in CKD.
Main Methods:
- Review of existing literature on CKD, aging, and cardiovascular disease.
- Analysis of pathogenic pathways linking CKD to vascular aging.
- Synthesis of current knowledge on risk factors and therapeutic approaches.
Main Results:
- CKD is linked to accelerated vascular aging via uremic toxins and chronic inflammation.
- Abnormal bone and mineral metabolism further contributes to cardiovascular pathology.
- Premature atherosclerosis and cardiovascular disease are hallmarks of advanced CKD.
Conclusions:
- Understanding CKD-specific cardiovascular risks is crucial for patient outcomes.
- Targeting uremic toxins, inflammation, and mineral metabolism may mitigate cardiovascular risk.
- Proactive prevention and intervention strategies are essential for this high-risk population.
Abstract:
Chronic kidney disease (CKD) is associated with premature cardiovascular morbidity and mortality. Traditional Framingham risk factors contribute partially to the malignant form of cardiovascular disease in CKD. Uremic-specific risk factors including chronic inflammation, retention of uremic toxins, and abnormal bone mineral metabolism have independently been linked to the pathogenesis of premature vascular aging, atherosclerosis, and cardiovascular disease. In this review we explore the mechanisms by which premature aging occurs in CKD through its pathologic effects on cardiovascular health, and the determinants of cardiac disease in patients with CKD. We outline strategies for prevention and therapeutic interventions in this vulnerable population.
Related Concept Videos
08:50Assessment of Vascular Function in Patients With Chronic Kidney Disease
Chronic Kidney Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management